Found: 5
Select item for more details and to access through your institution.
The microtubule inhibitor eribulin demonstrates efficacy in platinum-resistant and refractory high-grade serous ovarian cancer patient-derived xenograft models.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231208674
- By:
- Publication type:
- Article
NLRP1 restricts butyrate producing commensals to exacerbate inflammatory bowel disease.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-06125-0
- By:
- Publication type:
- Article
BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance.
- Published in:
- Molecular Cancer, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12943-024-02048-1
- By:
- Publication type:
- Article
Adverse effects of isoniazid preventative therapy for latent tuberculosis infection: a prospective cohort study.
- Published in:
- Drug, Healthcare & Patient Safety, 2014, v. 6, p. 145, doi. 10.2147/DHPS.S68837
- By:
- Publication type:
- Article
A single‐cell RNA expression atlas of normal, preneoplastic and tumorigenic states in the human breast.
- Published in:
- EMBO Journal, 2021, v. 40, n. 11, p. 1, doi. 10.15252/embj.2020107333
- By:
- Publication type:
- Article